Philips Respironics is exhibiting its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) International Congress 2016 in London
At the event, the company is highlighting the Dream Family connected therapy system, announcing its extension with the introduction of BiPAP autoSV and BiPAP AVAPS therapy devices.
According to Philips there are over 100 million people worldwide who suffer from obstructive sleep apnea and it claims that its products which offer positive airway pressure (PAP) have had an effective role in treating the condition.
It also claims that its 40 years of experience and over 10 years of cloud-based data sharing experience, it has improved the condition in over 7 million patients, who have been supported through its EncoreAnywhere compliance management system.
The Dutch company said that it’s fully integrated, connected solutions and coaching tools for patients, have also helped physicians and care providers in better managing the condition in patients.
Philips sleep business leader Mark D’Angelo said: “Philips Respironics has a long history of creating innovative technologies that are clinically proven to improve adherence and the overall patient experience.
“Continuing to build on the connectivity and usability of our solutions is an important way for us to better address the needs of patients by offering consistent support throughout their therapy, helping them live better lives.”
The Dream Family to be showcased by Philips is an integrated therapy solution which includes DreamStation PAP device, DreamWear mask and DreamMapper patient engagement application.
EncoreAnywhere is used web-based platform for patient compliance management system, which offer physicians with insight and required tools to enhance overall patient care.